Characteristic | Overall N = 714 | SHR1 (SHR ≤ 0.79) N = 238 | SHR2 (0.79 < SHR ≤ 1.10) N = 238 | SHR3 (SHR > 1.10) N = 238 | P value |
---|---|---|---|---|---|
Age, mean (SD), yrs | 62.0 (10.4) | 61.4 (11.2) | 61.4 (9.5) | 63.1 (10.4) | 0.109 |
Male, No. (%) | 535 (74.9) | 181 (76.1) | 179 (75.2) | 175 (73.5) | 0.812 |
SBP, mean (SD), mmHg | 141.6 (24.9) | 141.7 (24.2) | 144.7 (24.0) | 138.3 (26.1) | 0.020 |
DBP, mean (SD), mmHg | 78.3 (13.4) | 77.7 (12.7) | 79.9 (13.9) | 77.3 (13.4) | 0.066 |
Heart rate, mean (SD), beats/min | 80.4 (15.0) | 77.6 (14.7) | 79.8 (12.4) | 83.6 (17.1) | < 0.001 |
Medical history and risk factors, No. (%) | Â | Â | Â | Â | Â |
Hypertension | 661 (92.6) | 214 (89.9) | 227 (95.4) | 220 (92.4) | 0.075 |
Diabetes mellitus | 450 (63.0) | 132 (55.5) | 158 (66.4) | 160 (67.2) | 0.012 |
Current smoker | 127 (17.8) | 48 (20.2) | 49 (20.6) | 30 (12.6) | 0.037 |
Atrial fibrillation | 63 (8.8) | 17 (7.1) | 21 (8.8) | 25 (10.5) | 0.434 |
Cerebrovascular disease | 139 (19.5) | 39 (16.4) | 45 (18.9) | 55 (23.1) | 0.174 |
Valvular disease | 24 (3.4) | 8 (3.4) | 7 (2.9) | 9 (3.8) | 0.879 |
Peripheral arterial disease | 74 (10.4) | 22 (9.2) | 25 (10.5) | 27 (11.3) | 0.751 |
Previous myocardial infarction | 103 (14.4) | 40 (16.8) | 33 (13.9) | 30 (12.6) | 0.408 |
Previous intervention, No. (%) | Â | Â | Â | Â | Â |
PCI | 144 (20.2) | 58 (24.4) | 44 (18.5) | 42 (17.6) | 0.138 |
CABG | 12 (1.7) | 5 (2.1) | 4 (1.7) | 3 (1.3) | 0.775 |
Dialysis modality, No. (%) | Â | Â | Â | Â | 0.010 |
Hemodialysis | 655 (91.7) | 225 (94.5) | 222 (93.3) | 208 (87.4) | Â |
Peritoneal dialysis | 59 (8.3) | 13 (5.5) | 16 (6.7) | 30 (12.6) | Â |
Vintage, yrs | Â | Â | Â | Â | 0.163 |
<1 | 151 (21.1) | 39 (16.4) | 62 (26.1) | 50 (21.0) | Â |
1–5 | 339 (47.5) | 119 (50.0) | 112 (47.1) | 108 (45.4) |  |
5–10 | 183 (25.6) | 68 (28.6) | 50 (21.0) | 65 (27.3) |  |
≥10 | 41 (5.7) | 12 (5.0) | 14 (5.9) | 15 (6.3) |  |
Cause of dialysis, No. (%) | Â | Â | Â | Â | 0.022 |
Diabetes mellitus | 267 (37.4) | 73 (30.7) | 98 (41.2) | 96 (40.3) | Â |
Hypertension | 87 (12.2) | 39 (16.4) | 25 (10.5) | 23 (9.7) | Â |
Glomerulonephritis | 168 (23.5) | 67 (28.2) | 54 (22.7) | 47 (19.7) | Â |
Other/unknown | 192 (26.9) | 59 (24.8) | 61 (25.6) | 72 (30.3) | Â |
Index presentation, No. (%) | Â | Â | Â | Â | 0.037 |
AMI | 450 (63.0) | 137 (57.6) | 149 (62.6) | 164 (68.9) | Â |
Unstable angina | 264 (37.0) | 101 (42.4) | 89 (37.4) | 74 (31.1) | Â |
Hemoglobin, g/L | 105.7 (19.4) | 105.2 (20.1) | 108.2 (19.3) | 103.7 (18.5) | 0.038 |
ABG, | 8.0 (4.4) | 5.1 (1.8) | 7.5 (2.6) | 11.5 (5.2) | < 0.001 |
HbA1c, % | 6.5 (1.7) | 6.7 (1.7) | 6.7 (1.7) | 6.3 (1.9) | 0.011 |
Serum creatinine, mg/dl | 8.9 (3.2) | 9.5 (3.3) | 8.8 (2.9) | 8.6 (3.3) | 0.007 |
GRACE score | 157.0 [133.0, 182.0] | 150.5 [130.0, 173.0] | 155.5 [133.0, 181.0] | 161.0 [139.2, 188.0] | 0.001 |
Procedure characteristic, No. (%) | Â | Â | Â | Â | Â |
Radial access | 529 (74.1) | 174 (73.1) | 173 (72.7) | 182 (76.5) | 0.587 |
Extent of disease | Â | Â | Â | Â | Â |
Any left main disease | 91 (12.7) | 32 (13.4) | 30 (12.6) | 29 (12.2) | 0.916 |
2-vessel disease | 187 (26.2) | 55 (23.1) | 57 (23.9) | 75 (31.5) | 0.072 |
≥3-vessel disease | 426 (59.7) | 150 (63.0) | 144 (60.5) | 132 (55.5) | 0.231 |
Moderate or severe calcification | 324 (45.4) | 115 (48.3) | 100 (42.0) | 109 (45.8) | 0.381 |
PCI treatment | 512 (71.7) | 174 (73.1) | 173 (72.7) | 165 (69.3) | 0.604 |
Discharge medications, No. (%) | Â | Â | Â | Â | Â |
Dual antiplatelet therapy | 628 (88.0) | 215 (90.3) | 202 (84.9) | 211 (88.7) | 0.172 |
Aspirin | 664 (93.0) | 232 (97.5) | 212 (89.1) | 220 (92.4) | NA |
Clopidogrel | 596 (83.5) | 200 (84.0) | 195 (81.9) | 201 (84.5) | NA |
Ticagrelor | 69 (9.7) | 21 (8.8) | 25 (10.5) | 23 (9.7) | NA |
ACE inhibitor or ARB | 343 (48.0) | 120 (50.4) | 111 (46.6) | 112 (47.1) | 0.664 |
β-blocker | 587 (82.2) | 188 (79.0) | 199 (83.6) | 200 (84.0) | 0.280 |
Calcium-channel blocker | 467 (65.4) | 161 (67.6) | 163 (68.5) | 143 (60.1) | 0.105 |
Statin | 678 (95.0) | 228 (95.8) | 223 (93.7) | 227 (95.4) | 0.541 |